| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
in Malignant Gynecological Cell Lines Is Associated with the Expression of Protein(s) That Prevent the Activation of Phospholipase A2 by Tumor Necrosis Factor
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri 63110
Although there are a limited number of cell lines that are sensitive to cytolysis by tumor necrosis factor
(TNF
), the vast majority are resistant. The analysis of TNF
-sensitive cells has shown that phospholipase A2 is activated by TNF
in these cells and that the activity of phospholipase A2 is required for their cytolysis. Many cell lines that are resistant to TNF
-mediated cytolysis are dependent on the maintenance of protein synthesis for their resistance. We have recently shown that this is also true for TNF
-resistant cell lines derived from cervical (ME-180 and SiHa) and ovarian (SK-OV-3 and OVCAR-3) carcinomas, in that they are sensitive to cytolysis by TNF
only in the presence of protein synthesis inhibitors. Here we show that the TNF
-mediated cytolysis of these resistant cell lines in the presence of the protein synthesis inhibitor emetine is similar to that of sensitive cells, in that cytolysis is inhibited by the inhibitors of phospholipase A2. The measurement of the release of radiolabeled material from cervical and ovarian carcinoma cell lines prelabeled with [3H]arachidonic acid showed that not only was phospholipase A2 required for the cytolysis of these cells by TNF
in the presence of protein synthesis inhibitors, but more importantly, phospholipase A2 was not activated by TNF
unless protein synthesis was inhibited. These results indicate that a protein synthesis-dependent resistance mechanism expressed by these cell lines blocks TNF
-mediated cytolysis by preventing the activation of phospholipase A2 by TNF
.
1 Supported by American Cancer Society Career Development Award (19901993).
2 Current address: University of California at San Francisco, Division of Gynecologic Oncology, 350 Parnassus Avenue, Suite 300, San Francisco, CA 94117.
3 To whom requests for reprints should be addressed, at: Department of Obstetrics and Gynecology, Washington University School of Medicine, 4911 Barnes Hospital Plaza, St. Louis, MO 63110.
Received 4/ 8/91. Accepted 11/19/91.
This article has been cited by other articles:
![]() |
D. W. Draper, V. G. Harris, C. A. Culver, and S. M. Laster Calcium and Its Role in the Nuclear Translocation and Activation of Cytosolic Phospholipase A2 in Cells Rendered Sensitive to TNF-Induced Apoptosis by Cycloheximide J. Immunol., February 15, 2004; 172(4): 2416 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kramer, E. O. Harrington, Q. Lu, R. Bellas, J. Newton, K. L. Sheahan, and S. Rounds Isoprenylcysteine Carboxyl Methyltransferase Activity Modulates Endothelial Cell Apoptosis Mol. Biol. Cell, March 1, 2003; 14(3): 848 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Wu, X.-R. Jiang, A. C. Newland, and S. M. Kelsey Failure to Activate Cytosolic Phospholipase A2 Causes TNF Resistance in Human Leukemic Cells J. Immunol., June 15, 1998; 160(12): 5929 - 5935. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wissing, H. Mouritzen, M. Egeblad, G. G. Poirier, and M. Jaattela Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis PNAS, May 13, 1997; 94(10): 5073 - 5077. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cai, A. Bettaieb, N. E. Mahdani, L. G. Legres, R. Stancou, J. Masliah, and S. Chouaib Alteration of the Sphingomyelin/Ceramide Pathway Is Associated with Resistance of Human Breast Carcinoma MCF7 Cells to Tumor Necrosis Factor-alpha -mediated Cytotoxicity J. Biol. Chem., March 14, 1997; 272(11): 6918 - 6926. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Scorrano, D. Penzo, V. Petronilli, F. Pagano, and P. Bernardi Arachidonic Acid Causes Cell Death through the Mitochondrial Permeability Transition. IMPLICATIONS FOR TUMOR NECROSIS FACTOR-alpha APOPTOTIC SIGNALING J. Biol. Chem., April 6, 2001; 276(15): 12035 - 12040. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |